Scholarlink

Prostate cancer is a global health challenge. According to the National Centre for Disease Informatics and Research (NCDIR), prostate cancer was amongst top ten cancers in urban cancer registries of Delhi, Bangalore, Bhopal and Mumbai in 2022. Localized prostate cancer is classified into low, intermediate and high risk based on the T-stage, serum prostate-specific antigen (PSA) and Gleason score (GS). Outcome in low-risk prostate cancer patients is excellent, and the treatment options include active surveillance, external beam radiotherapy or brachytherapy and radical prostatectomy, balancing benefit and potential overtreatment.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Management of Very Low- and Low-Risk Prostate Cancer

  • 章节

  • 发表日期：

    2026年

查看全文
  • Renu Madan,
  • Girdhar Bora,
  • Shikha Goyal,
  • Narendra Kumar

摘要

Prostate cancer is a global health challenge. According to the National Centre for Disease Informatics and Research (NCDIR), prostate cancer was amongst top ten cancers in urban cancer registries of Delhi, Bangalore, Bhopal and Mumbai in 2022. Localized prostate cancer is classified into low, intermediate and high risk based on the T-stage, serum prostate-specific antigen (PSA) and Gleason score (GS). Outcome in low-risk prostate cancer patients is excellent, and the treatment options include active surveillance, external beam radiotherapy or brachytherapy and radical prostatectomy, balancing benefit and potential overtreatment.